×
News Home

NovaBay Pharmaceuticals, Inc. (NBY) Stock Gains 24.14% This Week: Is It a Good Pick?

Tuesday, July 27, 2021 01:56 PM | InvestorsObserver Analysts
NovaBay Pharmaceuticals, Inc. (NBY) Stock  Gains 24.14% This Week: Is It a Good Pick?

NovaBay Pharmaceuticals, Inc. (NBY) stock has fallen -37.39% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NBY stock a score of 4 out of a possible 100. That rank is influenced by a fundamental score of 0. NBY stock has a mean target price of $1.90. This means analysts expect the stock to gain 163.89% over the next 12 months. NBY's rank also includes a short-term technical score of 2. The long-term technical score for NBY is 11.

Overall Score - 4
NBY has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on NBY!

What's Happening with NBY Stock Today

NovaBay Pharmaceuticals, Inc. (NBY) stock is up 16.21% while the S&P 500 has fallen -0.98% as of 1:55 PM on Tuesday, Jul 27. NBY is up $0.10 from the previous closing price of $0.62 on volume of 15,578,263 shares. Over the past year the S&P 500 has risen 35.18% while NBY has fallen -37.39%. NBY lost -$0.31 per share in the over the last 12 months. Click Here to get the full Stock Report for NovaBay Pharmaceuticals, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App